Evidence map›Paper›PMID 33937017›Full record

ArticleFrontiers in oncology2021

Imaging 6-Phosphogluconolactonase Activity in Brain Tumors

Georgios Batsios, Céline Taglang, Peng Cao, Anne Marie Gillespie, Chloé Najac, Elavarasan Subramani, David M Wilson, Robert R Flavell, Peder E Z Larson, Sabrina M Ronen and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in oncology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Quo Vadis HyperpolarizedZeitschrift fur medizinische Physik · 2025
    Review
  7. Article
  8. Hyperpolarized δ-[1-Scientific reports · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Georgios BatsiosDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Céline TaglangDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Peng CaoDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Anne Marie GillespieDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Chloé NajacDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Elavarasan SubramaniDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
David M WilsonDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Robert R FlavellDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Peder E Z LarsonDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Sabrina M RonenDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
Pavithra ViswanathDepartment of Radiology and Biomedical Imaging, University of California, San Francisco, CA, United States.
University of California, San Francisco · US

Funding

Translational InformaticsP30CA082103 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Kate Taylor Shumate · 1999 to 2026
$209.7M
Project 4: Multi-modality Metabolic Imaging for Monitoring Molecular Sub-types of GliomaP01CA118816 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Susan M Chang, Janine Marie Lupo · 2007 to 2026
$44.7M
TR&D3: Open-Source Tools for Processing Hyperpolarized MR DataP41EB013598 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Daniel B Vigneron · 2011 to 2026
$19.9M
Metabolic Reprogramming in Brain TumorsR01CA172845 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RONEN, SABRINA MIRIAM · 2013 to 2022
$6.3M
Metabolic Imaging of Brain Tumor Response to TherapyR01CA197254 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RONEN, SABRINA MIRIAM · 2016 to 2020
$3.2M
IMAGING TELOMERE MAINTENANCE MECHANISMS IN GLIOMASR01CA239288 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI RONEN, SABRINA MIRIAM, VISWANATH, PAVITHRA · 2020 to 2024
$3.2M
Application of hyperpolarized 13C interstitial pH imaging to risk stratification in prostate cancerR21EB026012 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI FLAVELL, ROBERT RICHARD · 2018 to 2020
$503k
NCI NIH HHS P01 CA118816NCI NIH HHS P30 CA082103NCI NIH HHS R01 CA172845NCI NIH HHS R01 CA197254NCI NIH HHS R01 CA239288NIBIB NIH HHS P41 EB013598NIBIB NIH HHS R21 EB026012
6 · The paper itself

Abstract

introductionThe pentose phosphate pathway (PPP) is essential for NADPH generation and redox homeostasis in cancer, including glioblastomas. However, the precise contribution to redox and tumor proliferation of the second PPP enzyme 6-phosphogluconolactonase (PGLS), which converts 6-phospho-δ-gluconolactone to 6-phosphogluconate (6PG), remains unclear. Furthermore, non-invasive methods of assessing PGLS activity are lacking. The goal of this study was to examine the role of PGLS in glioblastomas and assess the utility of probing PGLS activity using hyperpolarized δ-[1-

methodsTo interrogate the function of PGLS in redox, PGLS expression was silenced in U87, U251 and GS2 glioblastoma cells by RNA interference and levels of NADPH and reduced glutathione (GSH) measured. Clonogenicity assays were used to assess the effect of PGLS silencing on glioblastoma proliferation. Hyperpolarized δ-[1-

resultsPGLS knockdown downregulated NADPH and GSH, elevated oxidative stress and inhibited clonogenicity in all models. Conversely, PGLS expression and activity and steady-state NADPH and GSH were higher in tumor tissues from rats bearing orthotopic glioblastoma xenografts relative to contralateral brain and tumor-free brain. Importantly, [1-

conclusionsCollectively, we have, for the first time, identified a role for PGLS activity in glioblastoma proliferation and validated the utility of probing PGLS activity using hyperpolarized δ-[1-

Indexed as

6-phosphogluconolactonase (PGLS)brain tumorsdynamic nuclear polarization (DNP)glioblastomahyperpolarized 13C MRSmagnetic resonance spectroscopy/imaging (MRS/I)metabolic therapypentose phosphate pathway (PPP)

Identifiers

PMID33937017
PMCPMC8082394
OpenAlexW3156414201

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.